Related Experiment Video
Updated: Oct 7, 2025

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Prevalence of peripheral neuropathy and associated risk factors in children with type 1 diabetes
Indrabhushan Singh1, Chaithanya Reddy2, Arushi Gahlot Saini2
1Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Insights
Nearly one-fifth of children with type 1 diabetes (T1D) develop subclinical diabetic polyneuropathy (DPN) within two years. Higher body mass index is a significant risk factor for DPN in pediatric patients.
Area of Science:
- Pediatric Endocrinology
- Neurology
- Metabolic Disorders
Background:
- Type 1 diabetes (T1D) is a chronic condition requiring lifelong management.
- Diabetic polyneuropathy (DPN) is a common complication, but its early prevalence in children is not well-defined.
- Early detection and risk factor identification are crucial for managing DPN in pediatric T1D patients.
Purpose of the Study:
- To determine the prevalence of diabetic polyneuropathy (DPN) in children with type 1 diabetes (T1D).
- To identify risk factors associated with the development of DPN in this population.
Main Methods:
- A cross-sectional study involving children aged 2-16 years with T1D for at least 2 years.
- Comprehensive neurological examinations, neuropathy symptom scores, and nerve conduction studies were performed.
- Disease-related factors were analyzed to predict neuropathy development.
Main Results:
- The prevalence of subclinical DPN was 18.2% among the 66 children studied.
- Pure motor neuropathy was most common (91.6%), affecting primarily the common peroneal nerve.
- Children with subclinical DPN showed significant reductions in nerve conduction velocities and increased latencies, with higher BMI being a predictor (p<0.05).
Conclusions:
- Subclinical DPN affects nearly one-fifth of children with T1D within two years of diagnosis.
- Elevated body mass index is a significant risk factor for DPN in children with T1D.
- Regular electrophysiological screening is recommended for early detection and monitoring of nerve dysfunction.
Aim:
To detect the prevalence of diabetic polyneuropathy (DPN) in children with type 1 diabetes (T1D) and to identify associated the risk factors.
Methods:
This cross-sectional study evaluated children aged between 2 and 16y with T1D for ≥2 y. Detailed neurological examination, neuropathy symptom score, and nerve conduction studies were done in all children to assess nerve dysfunction. Disease-related factors were evaluated for the prediction of neuropathy.
Results:
Sixty-six children (67% boys) were enrolled. The mean age at the time of diagnosis of T1D was 7.1 ± 2.6 years. The mean duration of diabetes was 4 ± 1.8 years. None of the patients had neuropathy on clinical examination or on the neuropathy symptom score. The prevalence of subclinical DPN was 18.2% (n = 12/66). The type of neuropathy was pure motor (n = 11, 91.6%) and mixed sensorimotor (n = 1, 8.3%). The common peroneal nerve was most commonly affected (n = 6, 50%), followed by the tibial (n = 4, 33.3%) nerve. The most common patterns of nerve involvement were mixed axonal and demyelination (n = 7, 58.3%), followed by axonal (n = 3, 25%) and demyelinating type (n = 2, 16.6%). Children with subclinical DPN had a significant reduction in velocity of tibial, common peroneal, median motor, and ulnar motor nerves; delayed latency in common peroneal, median motor, ulnar motor, and median sensory nerves compared to those without DPN (p value <0.05). A higher body mass index predicted the development of subclinical DPN (p value <0.05).
Conclusion:
Nearly one-fifth of children with T1D have subclinical neuropathy as early as two years of the disease. A higher body mass index is significantly associated with DPN. Electrophysiological studies should be performed regularly to screen for nerve dysfunction and its progression.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

